ABL1 and leukemia: Overall survival of patients with leukemias in the context of ABL1 expression levels revealed that chronic lymphocytic leukemia (CLL) and AML displaying low levels of ABL1 mRNA expression had shorter overall survival, while opposite effect was detected in ALL (Fig. 1C).